Shannon van Hoorn

Assistant professor

Erasmus University Rotterdam
Country flagNetherlands

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shannon van Hoorn is an Assistant Professor at Erasmus University Rotterdam in the Netherlands. Her research encompasses a range of topics including prognostic models in acute neurologic care, patient experiences in value-based healthcare, and psychometrics related to inherited bleeding disorders. Recent publications reflect her focus on both qualitative aspects of patient care and the ethical considerations of gene therapy for hemophilia.

Articles (10)

Year:

2025

Year:

2025

Background: Healthcare services worldwide are transforming themselves into value-based organizations. Integrated care is an important aspect of value-based healthcare (VBHC), but practical evidence-based recommendations for the successful implementation of integrated care within a VBHC context are lacking. This systematic review aims to identify how value-based integrated care (VBIC) is defined in literature, and to summarize the literature regarding the effects of VBIC, and the facilitators and barriers for its implementation. Methods: Embase, Medline ALL, Web of Science Core Collection, and Cochrane Central Register of Controlled Trails databases were searched from inception until January 2022. Empirical studies that implemented and evaluated an integrated care intervention within a VBHC context were included. Non-empirical studies were included if they described either a definition of VBIC or facilitators and barriers for its implementation. Theoretical articles and articles without an available full text were excluded. All included articles were analysed qualitatively. The Rainbow Model of Integrated Care (RMIC) was used to analyse the VBIC interventions. The quality of the articles was assessed using the Mixed Methods Appraisal Tool (MMAT). Results: After screening 1328 titles/abstract and 485 full-text articles, 24 articles were included. No articles were excluded based on quality. One article provided a definition of VBIC. Eleven studies reported—mostly positive— effects of VBIC, on clinical outcomes, patient-reported outcomes, and healthcare utilization. Nineteen studies reported facilitators and barriers for the implementation of VBIC; factors related to reimbursement and information technology (IT) infrastructure were reported most frequently. Conclusion: The concept of VBIC is not well defined. The effect of VBIC seems promising, but the exact interpretation of effect evaluations is challenged by the precedence of multicomponent interventions, multiple testing and generalizability issues. For successful implementation of VBIC, it is imperative that healthcare organizations consider investing in adequate IT infrastructure and new reimbursement models. Systematic Review Registration: PROSPERO (CRD42021259025).

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (5)

Karin Fijnvandraat

Professor of Pediatric Hematology

Amsterdam UMC Locatie VUmc

NETHERLANDS
View details

Michiel Luijten

Amsterdam UMC Locatie VUmc

NETHERLANDS
View details

Hester F. Lingsma

Erasmus University Medical Center

NETHERLANDS
View details

Kathelijn Fischer

-

NETHERLANDS
View details

Samantha C. Gouw

-

NETHERLANDS
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.